-
Uncategorized2 months ago
Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts, but no deals in the works
Novartis is “continuing to evaluate” the in vivo CAR-T space, although the pharma’s CEO has told Fierce Biotech that no deals are currently in the works.Read...
-
Uncategorized2 months ago
Heritable immunization of mice against Lyme disease enables ecological disease prevention
Post Content
-
Uncategorized2 months ago
Shedding light on the undiscovered pathways of yeast metabolism
Post Content
-
Uncategorized2 months ago
Historic FDA approval brings first gene therapy for genetic deafness
Nature Biotechnology, Published online: 28 April 2026; doi:10.1038/s41587-026-03145-w The first-of-its-kind genetic medicine treats a rare and profound otoferlin-related hearing loss, and will be made available by...
-
Uncategorized2 months ago
Retron-Powered Approach Enables Genome Editing Across Diverse Bacterial Species
For decades, the ability to precisely rewrite bacterial genomes has been largely confined to a single workhorse organism: Escherichia coli. That limitation has slowed efforts to...
-
Uncategorized2 months agoNew U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
A new U.S. policy that recommends offering hepatitis B vaccine at birth only to babies perceived to be at risk of neonatal infection will lead to...
-
Uncategorized2 months agoSTAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
The drugmaker Erasca said Monday that its RAS-targeting pill shrank tumors in 40% of patients with advanced pancreatic cancer and 62% of patients with advanced non-small...
-
Uncategorized2 months ago
Erasca reports RAS cancer drug data after legal threat from Revolution
Erasca reports RAS cancer drug data after legal threat from Revolution
-
Uncategorized2 months ago
Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase
Sun Pharmaceutical Industries has agreed to acquire Organon, the women’s health drug developer spun out of Merck & Co., for $11.75 billion in a deal intended...
-
Uncategorized2 months agoDems say RFK Jr. has a pattern of failing to answer their questions
WASHINGTON — Last week, Sen. Ben Ray Luján (D-N.M.) asked health secretary Robert F. Kennedy Jr. whether he would release — by Friday — the contract...
